Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
β-Nicotinamide mononucleotide
Cat. No.:
OB0425LY-322
Appearance:
Solid
Purity:
99.9%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
β-nicotinamide mononucleotide is a key product of the nicotinamide phosphoribosyltransferase (NAMPT) reaction and a key NAD+ intermediate.
Synonyms:
1094-61-7; beta-Nicotinamide mononucleotide; Nicotinamide mononucleotide; Nicotinamide ribotide; beta-NMN; Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)-, inner salt; ((2R,3S,4R,5R)-5-(3-Carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate
CAS No.:
1094-61-7
Compound CID:
14180
Formula:
C11H15N2O8P
Formula Weight:
334.22
Specification
Target:
Endogenous metabolite
Pathway:
Metabolic enzyme/Protease
Solubility:
Water
Storage:
Storage at 4°C.
Applications:
β-nicotinamide mononucleotide has pharmacological effects including its role in cellular biochemical function, cardioprotection, diabetes, Alzheimer's disease, and complications associated with obesity.
